Study ties drug shortage to poorer cancer survival
Photo credit: St. Jude Children's Research Hospital | Abby Alonzo during her treatment at St. Jude's. Alonzo was one of many young cancer patients who couldn't get a key medicine during treatment because of a national drug shortage.
Young cancer patients who couldn't get a key medicine because of a national drug shortage were more likely to suffer a relapse than others who were able to get the preferred treatment, doctors report. It's the first evidence that a long-standing drug-supply problem probably has affected cancer treatment results in specific patients.
The study involved more than 200 children and young adults...
